Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 285 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Active, Not Recruiting

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

NCT04390399

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • Hoag memorial Presbyterian Hospital Newport Beach, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View Trial Details
Active, Not Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

NCT02921022

Conditions
Advanced Pancreatic Ductal Adenocarcinoma, Cardiovascular Diseases, Digestive System Diseases, +11 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

NCT03563248

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT05163028

Conditions
Bronchial Neoplasms, Cancer, Cancer of Colon, +28 more
Locations
  • City of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos, California, United States
View Trial Details

Related conditions